End-stage renal disease and African American race are independent predictors of mild liver fibrosis in patients with chronic hepatitis C infection

Journal of Viral Hepatitis

Volumn 19, Issue 5, 2012, Pages 371-376

  Aslinia, Florence M ^a   Wasan, S K ^b   Mindikoglu, A L ^a   Adeyemo, O A ^a   Philosophe, B ^a   Drachenberg, C ^a   Howell, C D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; End stage renal disease; Hepatitis C; Liver fibrosis

Indexed keywords

ALKALINE PHOSPHATASE;

ADULT; AFRICAN AMERICAN; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEPATITIS C; HUMAN; KIDNEY FAILURE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL;

ADULT; AFRICAN AMERICANS; BIOPSY; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEPATITIS C, CHRONIC; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SERUM; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 84859843732     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2011.01565.x     Document Type: Article

References (25)

1. Fleckenstein J. Chronic hepatitis C in African Americans and other minority groups. Curr Gastroenterol Rep 2004; 6: 66-70. (Pubitemid 39359587)
2. Meers CM, Seeff LB, Stehman-Breen CO et al. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003; 42: 631-657. (Pubitemid 37187365)
3. Fissell RB, Bragg-Gresham JL, Woods JD et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int 2004; 65: 2335-2342. (Pubitemid 38670020)
4. Pereira BJ, Natov SN, Bouthot BA et al. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group. Kidney Int 1998; 53: 1374-1381. (Pubitemid 28316901)
5. Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11: 1896-1902.
6. Cotler SJ, Diaz G, Gundlapalli S et al. Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 2002; 35: 191-195. (Pubitemid 34815860)
7. Sterling RK, Sanyal AJ, Luketic VA et al. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 94: 3576-3582.
8. Hu KQ, Lee SM, Hu SX, Xia VW, Hillebrand DJ, Kyulo NL. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function. Am J Gastroenterol 2005; 100: 2010-2018.
9. Li S, McAlpine DD, Liu J, Li S, Collins AJ. Differences between blacks and whites in the incidence of end-stage renal disease and associated risk factors. Adv Ren Replace Ther 2004; 11: 5-13. (Pubitemid 38174670)
10. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562. (Pubitemid 29384163)
11. Crosse K, Umeadi OG, Anania FA et al. Racial differences in liver inflammation and fibrosis related to chronic hepatitis C. Clin Gastroenterol Hepatol 2004; 2: 456-458.
12. Wiley TE, Brown J, Chan J. Hepatitis C infection in African Americans: its natural history and histological progression. Am J Gastroenterol 2002; 97: 700-706. (Pubitemid 34245901)
13. Sterling RK, Stravitz RT, Luketic VA et al. A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans. Clin Gastroenterol Hepatol 2004; 2: 469-473. (Pubitemid 38698361)
14. Knodell RG, Ishak KG, Black WC et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435. (Pubitemid 12218164)
15. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 3-10. (Pubitemid 34700756)
16. Contreras AM, Ruiz I, Polanco-Cruz G et al. End-stage renal disease and hepatitis C infection: comparison of alanine aminotransferase levels and liver histology in patients with and without renal damage. Ann Hepatol 2007; 6: 48-54. (Pubitemid 46407489)
17. Poynard T, Ratziu V, Charlotte F, Goodman Z, McHutchison J, Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 2001; 34: 730-739. (Pubitemid 32488789)
18. Wright M, Goldin R, Fabre A et al. Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut 2003; 52: 574-579. (Pubitemid 36363414)
19. Ryder SD, Irving WL, Jones DA, Neal KR, Underwood JC. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004; 53: 451-455. (Pubitemid 38241346)
20. Castéra L, Hézode C, Roudot-Thoraval F et al. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies. Gut 2003; 52: 288-292. (Pubitemid 36115074)
21. Rahman F, Rehermann B. Ethnicity and hepatitis C virus infection. Clin Gastroenterol Hepatol 2004; 2: 456-458. (Pubitemid 38698358)
22. Fontana RJ, Kleiner DE, Bilonick R et al. Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection. Hepatology 2006; 44: 925-935. (Pubitemid 46489557)
23. Rampino T, Arbustini E, Gregorini M et al. Hemodialysis prevents liver disease caused by hepatitis C virus: role of hepatocyte growth factor. Kidney Int 1999; 56: 2286-2291. (Pubitemid 30004760)
24. Sezer S, Tutal E, Aldemir D et al. Hepatitis C infection in hemodialysis patients: protective against oxidative stress?. Transplant Proc 2006; 38: 406-410.
25. Martin P, Carter D, Fabrizi F et al. Histopathological features of hepatitis C in renal transplant candidates. Transplantation 2000; 69: 1479-1484. (Pubitemid 30238744)